TGF-?1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis
- 20 April 1999
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 84 (2) , 155-159
- https://doi.org/10.1002/(sici)1097-0215(19990420)84:2<155::aid-ijc11>3.0.co;2-s
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Prognostic factors for acute and late skin reactions in radiotheraphy patientsInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Endoglin modulates cellular responses to TGF-beta 1.The Journal of cell biology, 1996
- Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurityThe Journal of Pediatrics, 1996
- Serum levels of the TGF-beta receptor are increased in atherosclerosisAtherosclerosis, 1996
- Long-term expression of transforming growth factor TGF beta1 in mouse skin after localized beta-irradiationInternational Journal of Radiation Biology, 1996
- Irradiation induces Up‐regulation of E9 protein (CD105) in human vascular endothelial cellsInternational Journal of Cancer, 1995
- Expression of Transforming Growth Factor-β1 in Mouse Skin During the Acute Phase of Radiation DamageInternational Journal of Radiation Biology, 1995
- Transforming growth factor-beta activation in irradiated murine mammary gland.Journal of Clinical Investigation, 1994
- Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes: Interrelationship between the alveolar macrophage and the septal fibroblastInternational Journal of Radiation Oncology*Biology*Physics, 1992
- β-Transforming Growth Factor is stored in human blood platelets as a latent high molecular weight complexBiochemical and Biophysical Research Communications, 1986